TABLE 2.

The relationship between prognostic related ubiquitin genes and clinicopathologic parameters.

Gene		Gender (male/female)	Grade (G1–2/G3–4)	Stage (I–II/III–IV)	T stage (T1–T2/T3–T4)	N stage (N0/N1-X)	M stage (M0/M1-X)
N		353/186	249/282	331/205	349/190	241/298	428/109
CDCA3	t-value	1.687	NA*	NA*	NA*	0.519	NA*
	P-value	0.092	<0.001	<0.001	<0.001	0.604	<0.001
CHFR	t-value	0.073	NA*	5.967	5.670	0.139	4.574
	P-value	0.942	<0.001	<0.001	<0.001	0.890	<0.001
CORO6	t-value	1.650	3.427	3.504	3.454	1.014	4.538
	P-value	0.100	<0.001	<0.001	<0.001	0.311	<0.001
RNF175	t-value	1.331	3.750	4.174	4.112	0.050	2.502
	P-value	0.184	<0.001	<0.001	<0.001	0.960	0.013
TRIM72	t-value	NA*	2.168	2.548	2.048	NA*	NA*
	P-value	0.373	0.031	0.011	0.041	0.888	0.086
VAV3	t-value	NA*	NA*	NA*	NA*	0.815	NA*
	P-value	0.323	<0.001	<0.001	<0.001	0.416	<0.001
WDR72	t-value	1.774	NA*	NA*	NA*	0.289	NA*
	P-value	0.077	<0.001	<0.001	<0.001	0.773	<0.001

NA, not available. *Non-parametric Mann-Whitney rank sum test. The statistical method was t-test or non-parametric Mann-Whitney rank sum test with only one test.